These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15133428)

  • 1. Statin safety: what to know.
    Bottorff MB
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):34-8. PubMed ID: 15133428
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment and treatment of lipids in elderly persons.
    Lavie CJ
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):2-3. PubMed ID: 15133422
    [No Abstract]   [Full Text] [Related]  

  • 3. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention with over-the-counter statins: a cautionary tale.
    Davidoff F
    Clin Pharmacol Ther; 2005 Sep; 78(3):218-20. PubMed ID: 16153392
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 7. Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease.
    Biccard BM; Sear JW; Foëx P
    Anaesthesia; 2005 Nov; 60(11):1106-14. PubMed ID: 16229696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on statins: 2003.
    Vaughan CJ; Gotto AM
    Circulation; 2004 Aug; 110(7):886-92. PubMed ID: 15313959
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.
    Gotto AM
    Circulation; 2006 Sep; 114(12):1310-4; discussion 1314. PubMed ID: 16982952
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of aggressive statin therapy.
    Conn Med; 2005; 69(6):339-41. PubMed ID: 16184860
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-induced diabetes: perhaps, it's the tip of the iceberg.
    Goldstein MR; Mascitelli L
    QJM; 2011 Feb; 104(2):174-8. PubMed ID: 21118868
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of rhabdomyolysis with statins].
    Magalhães ME
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():42-4. PubMed ID: 16400398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins, cardiovascular disease, and drug safety.
    Gotto AM
    Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study stirs debate about statin use in those without high cholesterol.
    Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin safety and drug interactions: clinical implications.
    Bottorff MB
    Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin label changes.
    Med Lett Drugs Ther; 2012 Mar; 54(1386):21. PubMed ID: 22421817
    [No Abstract]   [Full Text] [Related]  

  • 19. Achieving vascular risk factor targets: a survey of a London general practice.
    Levine AP; Mikhailidis DP; Moross T; Benson K; Gor M
    Angiology; 2008; 59(1):36-46. PubMed ID: 18319220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Life a Statin Deficiency State? Observations on Integrative Medicine, Whole-Person Healing, and Our Nation's Pivotal Moment in Healthcare.
    Dossey L
    Explore (NY); 2009; 5(4):181-5. PubMed ID: 19608103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.